Bank of America (BAC) and JPMorgan Chase (JPM) remain two of the most closely watched names in U.S. banking. Their relative performance often serves as a proxy for the health of the broader financial system. This comparison is useful for investors considering a diversified, scale-driven leader against a slightly smaller peer with a strong consumer deposit base and a leaner valuation. For traders, the pair also illustrates how sentiment can shift between quality momentum and value within the same sector. The sections below review recent results, growth drivers, and positioning to highlight the trade-offs.
Bank of America operates across consumer banking, commercial lending, investment banking, wealth management, and global markets. In recent quarters the company has seen higher net interest income, steady loan and deposit growth, and a recovery in its investment banking business. Its latest quarterly results showed net income rising 27% to $9.1 billion, with sales and trading revenue up 33% and investment banking fees up 50% year over year. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Even with these solid figures, BAC has trailed several large-bank peers over the past six months, rising roughly 17% versus a strong performance for JPM. The stock trades near the mid-$50s, below its 52-week high of about $65, and holds an analyst consensus of “Buy” with an average price target implying meaningful upside. A large, low-cost deposit base of roughly $2 trillion supports its funding advantage, while continued investment in digital banking and artificial intelligence remains central to its strategy. Berkshire Hathaway remains its largest shareholder.
JPMorgan Chase is the largest U.S. bank by assets and market value, with operations spanning consumer and community banking, a corporate and investment bank, and an asset and wealth management division. The company has delivered record results, reporting $21.2 billion in net income in its latest quarter, up 41% year over year, on record revenue of roughly $57 billion. Investment banking fees rose 30% to their highest level since 2021, markets revenue climbed 35%, and assets under management crossed $5 trillion for the first time.
JPM has shown stronger momentum than many peers, with its market capitalization approaching the $1 trillion threshold. The bank raised its quarterly dividend by 10% to $1.65 per share and authorized a $50 billion share repurchase program, supported by a common equity tier 1 capital ratio of 14.1% and a return on tangible common equity of 23%. Chief Executive Jamie Dimon has cautioned that risks such as geopolitical tensions, sticky inflation, and elevated asset prices remain present.
While both companies are systemically important U.S. banks, their business mixes differ in meaningful ways. JPM operates a larger corporate and investment bank, giving it more upside to a rebounding capital-markets and dealmaking cycle. BAC leans more heavily on a vast consumer and commercial deposit franchise, which provides stable, low-cost funding but also makes its earnings more sensitive to interest-rate movements.
On valuation, BAC trades at a lower price-to-earnings ratio, near 11.7 times, and offers a higher dividend yield of roughly 2.2%. JPM trades at a premium, around 15 times trailing earnings, with a strong performance, reflecting its scale, diversification, and stronger recent momentum. On the risk side, JPM has raised its full-year expense guidance, while BAC carries greater interest-rate sensitivity and has seen larger institutional ownership shifts. Both face shared macro risks, including credit quality and economic uncertainty.
In my own analysis I sometimes look at Tickeron’s AI Trading Bots to test how different automated strategies might perform on names like these. The platform offers a range of bots built around distinct styles, timeframes, and risk profiles, and the trending section highlights those showing the strongest results in the current environment. It provides a practical way to explore systematic approaches alongside traditional research.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active§ion=trades&via=john
BAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 37 cases where BAC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 76%.
The RSI Indicator entered the oversold zone -- be on the watch for BAC's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for BAC just turned positive on October 26, 2026. Looking at past instances where BAC's MACD turned positive, the stock continued to rise in 34 of 46 cases over the following month. The odds of a continued upward trend are 74%.
Following a +0.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAC advanced for three days, in 212 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
The Aroon Indicator for BAC entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 2 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.267) is normal, around the industry mean (1.492). P/E Ratio (11.366) is within average values for comparable stocks, (11.617). Projected Growth (PEG Ratio) (0.873) is also within normal values, averaging (2.139). Dividend Yield (0.026) settles around the average of (0.035) among similar stocks. P/S Ratio (3.643) is also within normal values, averaging (3.867).
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. BAC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 63 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 21, placing this stock slightly worse than average.
The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks